Benzinga | Mar 16, 2021 04:11PM EDT

Organogenesis Holdings Q4 EPS $0.15 Beats $0.13 Estimate, Sales $106.80M Beat $99.18M Estimate

Organogenesis Holdings (NASDAQ:ORGO) reported quarterly earnings of $0.15 per share which beat the analyst consensus estimate of $0.13 by 15.38 percent. This is a 475 percent increase over losses of $(0.04) per share from the same period last year. The company reported quarterly sales of $106.80 million which beat the analyst consensus estimate of $99.18 million by 7.68 percent. This is a 43.08 percent increase over sales of $74.64 million the same period last year.